entity

MGEA5 (OGA)

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MGEA5 (OGA): its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4Connections
1Hypotheses
1Analyses
3Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (3)

TargetRelationTypeStr
neurodegenerationassociated_withdisease0.40
o_glcnacase___glycosylation_signalinginvolved_inpathway0.40
OGAco_associated_withgene0.30

Incoming (1)

SourceRelationTypeStr
h-46e028b6targetshypothesis0.50

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Selective OGA Inhibition as 'Tau Stabilization' Strategy Wit 0.458 neurodegeneration Which tau PTMs are both disease-specific

Mentioning Analyses (1)

Scientific analyses that reference this entity

Which tau PTMs are both disease-specific and druggable with selective small mole

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.484

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate highlighted promising PTMs like K280 acetylation and O-GlcNAcylation

closed · Rounds: 4 · Score: 0.65 · 2026-04-13

Related Research

Hypotheses and analyses mentioning MGEA5 (OGA) in their description or question text

No additional research found